Legal Representation
Attorney
Sharon R. Smith
Application History
31 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 1, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 31, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 31, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 31, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 18, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 18, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 17, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 17, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 2, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 6, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 6, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 17, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 2, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 2, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 2, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 2, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 2, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 2, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 2, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 2, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 2, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 14, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 14, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 14, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 13, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 13, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 13, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 4, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 3, 2023 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 2, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 14, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Biological tissue, namely, live cells in the nature of smooth muscle cells, skeletal muscle cells, myocytes, fibroblasts, chondrocytes, adipocytes, myofibroblasts, ectodermal cells, hepatocytes, organ cells, liver cells, kidney cells, cardiac cells, pancreatic islet cells, cells present in the intestine, stem cells, osteoblasts, cells forming bone or cartilage, hematopoietic cells, parenchymal cells, stroma cells, totipotent cells, induced pluripotent stem cells, pluripotent cells, induced multipotent progenitor stem cells and progenitor cells for scientific and medical research use; artificial organs incorporating live human cells, namely, live biological tissue cultures for scientific and medical research, other than for medical and veterinary purposes
Class 005
Pharmaceutical preparations containing live cells in the nature of smooth muscle cells, skeletal muscle cells, myocytes, fibroblasts, chondrocytes, adipocytes, myofibroblasts, ectodermal cells, hepatocytes, organ cells, liver cells, kidney cells, cardiac cells, pancreatic islet cells, cells present in the intestine, stem cells, osteoblasts, cells forming bone or cartilage, hematopoietic cells, parenchymal cells, stroma cells, totipotent cells, induced pluripotent stem cells, pluripotent cells, induced multipotent progenitor stem cells and progenitor cells all for medical purposes for the treatment of organ failure, replacement of inadequately functioning organs from genetic and environmental diseases, and replacement of damaged tissue from traumatic bodily injury; biological implants, namely, live bone, skin, liver, cartilage, pancreas, and kidney tissue intended for subsequent implantation
Class 010
Medical device, namely, surgical devices that facilitate the implantation of artificial organs
Additional Information
Design Mark
The mark consists of the stylized wording "3DBIOLABS" positioned below a design featuring three stacked rectangular geometric shapes. The colors black and white represent background, outlining, shading, and transparent areas and are not claimed as features of the mark.
Pseudo Mark
THREE DIMENSIONAL BIO LABS
Classification
International Classes
001
005
010
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"3D BIOLABS"